Search

Your search keyword '"Sugawara, S."' showing total 1,602 results

Search Constraints

Start Over You searched for: Author "Sugawara, S." Remove constraint Author: "Sugawara, S." Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
1,602 results on '"Sugawara, S."'

Search Results

1. Demonstration of nuclear gamma-ray polarimetry based on a multi-layer CdTe Compton Camera

4. Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L)

8. OA01.04 Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results

9. P2.08-01 TROPION-Lung08: Datopotamab Deruxtecan Plus Pembrolizumab in Untreated Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC)

10. Reverberation Measurements of the Inner Radius of the Dust Torus in 17 Seyfert Galaxies

11. Comparison of Cerebral Blood Flow Patterns in Patients with Phantom Bite Syndrome with Their Corresponding Clinical Features

12. Application of spin polarized 19O beam to the study of oxygen motion in solid oxide fuel cell materials

13. Inter-Band Effects of Magnetic Field on Hall Conductivity in Multi Layered Massless Dirac Fermion System $\alpha$-(BEDT-TTF)$_2$I$_3$

14. Spin and Valley Splittings in Multilayered Massless Dirac Fermion System

16. Analysis of circulating miRNAs specifically increased in insulin resistance and/or high-LDL cholesterolemia - Analysis of metabolome, correlation with related diseases, and atherosclerotic risk assessment -

17. Effects of the Zero-Mode Landau Level on Inter-Layer Magnetoresistance in Multilayer Massless Dirac Fermion Systems

18. Pharmacotherapeutic outcomes in atypical odontalgia: determinants of pain relief

19. COORDINATED UPPER-TROPOSPHERE-TO-STRATOSPHERE BALLOON EXPERIMENT IN BIAK

21. Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years

26. MA06.04 Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study (WJOG11619L)

27. P1.15-11 Durvalumab + Olaparib vs Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: Outcomes from the Phase 2 ORION Study

28. PL03.09 IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC

29. EP08.02-118 TRUST-II: A Global Phase II Study for Taletrectinib inROS1fusion Positive Lung Cancer and Other Solid Tumors

30. 931MO Final overall survival analysis of phase III study of pemetrexed/cisplatin versus vinorelbine/cisplatin for completely resected non-squamous non-small cell lung cancer: The JIPANG Study

31. 974MO 5-year update from KEYNOTE-407: Pembrolizumab plus chemotherapy in squamous non-small cell lung cancer (NSCLC)

34. LBA48 CCTG BR.31: A global, double-blind placebo-controlled, randomized phase III study of adjuvant durvalumab in completely resected non-small cell lung cancer (NSCLC)

35. 1786O BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin + etoposide + nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II study

36. 1312P Datopotamab deruxtecan (Dato-DXd) vs docetaxel (DTX) in patients (pts) with advanced nonsquamous (NSQ) non-small cell lung cancer (NSCLC) with brain metastases (mets): Results from TROPION-Lung01

38. Novel multiplex analyses reveal disparate natural killer cell signalling pathway activation during lentivirus infection

40. 150 Lipid Abnormality, Current Diabetes and Age Affect Erectile Hardness ∼ An Analysis of Data from Complete Medical Checkups Performed at a Single Hospital in Japan

41. 77TiP TRUST-II: A global phase II study for taletrectinib in ROS1 fusion-positive lung cancer and other solid tumors

42. One-Neutron Removal Cross Sections for $$^{16}$$N Isomeric State

43. 120O Pembrolizumab (Pembro) with or without lenvatinib (Lenva) in first-line metastatic NSCLC with PD-L1 TPS ≥1% (LEAP-007): A phase III, randomized, double-blind study

48. 1332P A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)

49. LBA44 Primary results of a randomized phase II study of osimertinib plus bevacizumab versus osimertinib monotherapy for untreated patients with non-squamous non-small cell lung cancer harboring EGFR mutations: WJOG9717L study

Catalog

Books, media, physical & digital resources